Cargando…
Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis
BACKGROUND: Although combination therapy using clarithromycin, rifampicin, and ethambutol is recommended for patients with pulmonary Mycobacterium avium complex (MAC) disease, some patients do not tolerate it because of adverse effects or underlying diseases. The efficacy and safety of fluoroquinolo...
Autores principales: | Shuto, Hisayuki, Komiya, Kosaku, Goto, Akihiko, Kan, Takamasa, Honjo, Kokoro, Uchida, Sonoe, Takikawa, Shuichi, Yoshimatsu, Tetsuyuki, Yamasue, Mari, Hiramatsu, Kazufumi, Kadota, Jun-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347193/ https://www.ncbi.nlm.nih.gov/pubmed/32645105 http://dx.doi.org/10.1371/journal.pone.0235797 |
Ejemplares similares
-
Factors associated with atypical radiological findings of pulmonary tuberculosis
por: Goto, Akihiko, et al.
Publicado: (2019) -
Corticosteroid Therapy for Patients With Severe Fever With Thrombocytopenia Syndrome: A Nationwide Propensity Score–Matched Study in Japan
por: Shuto, Hisayuki, et al.
Publicado: (2023) -
A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19
por: Shuto, Hisayuki, et al.
Publicado: (2020) -
A Systematic Review of Factors Associated with Mortality among Patients with Mycobacterium avium Complex Lung Disease
por: Fujishima, Nobuhiro, et al.
Publicado: (2023) -
Association between sputum conversion and in-hospital mortality in elderly patients with pulmonary tuberculosis: a retrospective study
por: Nakamura, Yuta, et al.
Publicado: (2022)